Esya Labs
- Biotech or pharma, therapeutic R&D
- Diagnostics
- Medical device or technology
- Other R&D services
- Synthesis, analytic, diagnostic services
Building molecular diagnostics for Alzheimer's Disease and Parkinson's and aiding drug development by profiling the endo-lysosomal pathway. Esya's DNA probes can ratiometrically quantify ions within endocytic organelles such as Endosomes & Lysosomes.
In addition, Esya Labs is a certified service provider of Alamar Biosciences, offering targeted proteomics solutions including the NULISAseq CNS Disease Panel 120, Inflammation Panel and Mouse Panel. These high-sensitivity platforms detect low-abundance biomarkers, track disease progression and accelerate validation efforts.
Our multi-omics platform leverages multi-omics data through advanced AI models, coupled with bioinformatics analysis, providing robust insights for studies.